Detalhe da pesquisa
1.
Nanostructured Layered Terbium Hydroxide Containing NASIDs: In Vitro Physicochemical and Biological Evaluations.
J Nanosci Nanotechnol
; 18(8): 5320-5326, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29458583
2.
Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.
Bioorg Med Chem Lett
; 19(15): 4446-9, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19525110
3.
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.
Bioorg Med Chem Lett
; 18(4): 1318-22, 2008 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18242983
4.
Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer.
Artif Cells Nanomed Biotechnol
; 46(sup1): 616-628, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29381101
5.
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist.
J Med Chem
; 49(26): 7603-6, 2006 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17181143
6.
A versatile synthesis of 17-heteroaryl androstenes via palladium-mediated Suzuki cross-coupling with heteroaryl boronic acids.
Steroids
; 71(7): 585-90, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16566953
7.
Exploring the role of bromine at C(10) of (+)-4-[2-[4-(8-chloro-3,10-dibromo- 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidinyl]-2- oxoethyl]-1-piperidinecarboxamide (Sch-66336): the discovery of indolocycloheptapyridine inhibitors of farnesyl protein transferase.
J Med Chem
; 45(18): 3854-64, 2002 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-12190309
8.
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.
Bioorg Med Chem Lett
; 17(13): 3778-83, 2007 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17459706
9.
Synthesis and structure-activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists.
Bioorg Med Chem Lett
; 16(15): 4107-10, 2006 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16697193